ToolsThe story, in brief
NVIDIA BioNeMo Agent Toolkit Turns Biomolecular Models Into Callable Skills for AI Agents in Drug Discovery
NVIDIA just turned drug discovery into agent-callable skills. Task completion: 57% → 100%.
The KeyNews take
Why it matters
NVIDIA's BioNeMo Agent Toolkit operationalizes biomolecular AI models as composable agent skills, enabling multi-step drug discovery workflows with measurable efficiency gains—a practical bridge between foundation models and domain-specific scientific automation.
The key facts
5 to knowOpen-source BioNeMo Agent Toolkit ships with OpenFold3, DiffDock, GenMol as callable skills
Task completion rate improved from 57.1% to 100% in benchmarks
Token efficiency doubled in agent execution (Codex CLI + GPT-5.5 fast)
Skills framework includes purpose, inputs, artifacts, failure mode documentation
Target domain: AI-assisted drug discovery workflows
Go to the source
MarkTechPostmarktechpost.com
Publisher excerpt: NVIDIA's open-source BioNeMo Agent Toolkit turns biomolecular models like OpenFold3, DiffDock, and GenMol into documented, callable skills for AI agents. Each skill describes a model's purpose, inputs, artifacts, and failure modes, so an agent can select, run, and interpret it. In NVIDIA's…